PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Universal Med Finl & (2666.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINHK0000255361
SectorFinancial Services
IndustryCredit Services

Highlights

Market CapHK$8.70B
PE Ratio4.30
Revenue (TTM)HK$13.46B
Gross Profit (TTM)HK$4.14B
Year RangeHK$3.57 - HK$5.01
Target PriceHK$7.21

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Universal Med Finl &

Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in Universal Med Finl &, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-5.00%0.00%5.00%10.00%15.00%20.00%25.00%30.00%NovemberDecember2024FebruaryMarchApril
20.62%
22.14%
2666.HK (Universal Med Finl &)
Benchmark (^GSPC)

S&P 500

Returns By Period

Universal Med Finl & had a return of 4.23% year-to-date (YTD) and 1.27% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date4.23%5.84%
1 month11.96%-2.98%
6 months20.62%22.02%
1 year1.27%24.47%
5 years (annualized)0.22%11.44%
10 years (annualized)N/A10.46%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-10.91%7.25%-0.47%
2023-4.17%1.53%5.04%7.67%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 2666.HK is 49, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of 2666.HK is 4949
Universal Med Finl &(2666.HK)
The Sharpe Ratio Rank of 2666.HK is 5252Sharpe Ratio Rank
The Sortino Ratio Rank of 2666.HK is 4444Sortino Ratio Rank
The Omega Ratio Rank of 2666.HK is 4444Omega Ratio Rank
The Calmar Ratio Rank of 2666.HK is 5151Calmar Ratio Rank
The Martin Ratio Rank of 2666.HK is 5151Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Universal Med Finl & (2666.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


2666.HK
Sharpe ratio
The chart of Sharpe ratio for 2666.HK, currently valued at 0.07, compared to the broader market-2.00-1.000.001.002.003.004.000.07
Sortino ratio
The chart of Sortino ratio for 2666.HK, currently valued at 0.28, compared to the broader market-4.00-2.000.002.004.006.000.28
Omega ratio
The chart of Omega ratio for 2666.HK, currently valued at 1.03, compared to the broader market0.501.001.501.03
Calmar ratio
The chart of Calmar ratio for 2666.HK, currently valued at 0.04, compared to the broader market0.002.004.006.000.04
Martin ratio
The chart of Martin ratio for 2666.HK, currently valued at 0.13, compared to the broader market0.0010.0020.0030.000.13
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.05, compared to the broader market-2.00-1.000.001.002.003.004.002.05
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.98, compared to the broader market-4.00-2.000.002.004.006.002.98
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.36, compared to the broader market0.501.001.501.36
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.55, compared to the broader market0.002.004.006.001.55
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.05, compared to the broader market0.0010.0020.0030.008.05

Sharpe Ratio

The current Universal Med Finl & Sharpe ratio is 0.07. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
0.07
2.03
2666.HK (Universal Med Finl &)
Benchmark (^GSPC)

Dividends

Dividend History

Universal Med Finl & granted a 7.26% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.34 per share.


PeriodTTM20232022202120202019201820172016
DividendHK$0.34HK$0.34HK$0.36HK$0.31HK$0.29HK$0.27HK$0.24HK$0.17HK$0.13

Dividend yield

7.26%7.57%7.59%5.51%5.01%4.58%4.10%2.26%2.03%

Monthly Dividends

The table displays the monthly dividend distributions for Universal Med Finl &. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024HK$0.00HK$0.00HK$0.00
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.34HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.36HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.31HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.29HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2019HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.27HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2018HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.24HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2017HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.17HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2016HK$0.13HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%7.3%
Universal Med Finl & has a dividend yield of 7.26%, which means its dividend payment is significantly above the market average.
Payout Ratio
20.0%40.0%60.0%80.0%100.0%120.0%31.8%
Universal Med Finl & has a payout ratio of 31.78%, which is quite average when compared to the overall market. This suggests that Universal Med Finl & strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2024FebruaryMarchApril
-31.04%
-3.90%
2666.HK (Universal Med Finl &)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Universal Med Finl &. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Universal Med Finl & was 55.15%, occurring on Oct 31, 2022. The portfolio has not yet recovered.

The current Universal Med Finl & drawdown is 31.04%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-55.15%Jun 24, 2021335Oct 31, 2022
-43.55%Nov 1, 2017633May 28, 2020246May 27, 2021879
-36.26%Jul 14, 2015145Feb 12, 2016419Oct 25, 2017564
-5.5%Jun 8, 20218Jun 18, 20213Jun 23, 202111
-3.71%May 28, 20211May 28, 20214Jun 3, 20215

Volatility

Volatility Chart

The current Universal Med Finl & volatility is 9.37%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%NovemberDecember2024FebruaryMarchApril
9.37%
3.64%
2666.HK (Universal Med Finl &)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Universal Med Finl & over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items